Alzamend Neuro, Inc.

ALZN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001677077

SEC filings (opens in a new tab)

In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Alzamend Neuro, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of ALZN: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	20	22	+2
Shares	874.3K	3.26M	+2.38M (+272.6%)
Value	$1.66M	$4.01M	+$2.34M (+141.0%)

New holders (11)

Institutions that held Alzamend Neuro, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ALZN in Q1 2022
Institution	Shares	Value	% of portfolio
Truist Financial Corp	2,314,907	$2.85M	0.00%
RFG Advisory, LLC	250,000	$308.0K	0.02%
Qube Research & Technologies Ltd	78,465	$97.0K	0.00%
Cubist Systematic Strategies, LLC	37,900	$47.0K	0.00%
Bank of America Corp	28,197	$35.0K	0.00%
Squarepoint Ops LLC	19,601	$24.0K	0.00%
Forum Private Client Group LLC	16,302	$20.0K	0.02%
Tower Research Capital LLC (TRC)	12,249	$15.0K	0.00%
Kingsbury Capital Investment Advisors LLC	11,519	$14.0K	0.02%
Morgan Stanley	3,800	$5.00K	0.00%
Money Concepts Capital Corp	250	$0	0.00%

Sold out (9)

Institutions that held Alzamend Neuro, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of ALZN in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Merit Financial Group, LLC	50,000	$95.0K
Engineers Gate Manager LP	43,719	$83.0K
Group One Trading, L.P.	42,894	$82.0K
Virtu Financial LLC	23,079	$44.0K
Cutler Group LP	12,378	$23.0K
XTX Topco Ltd	11,134	$21.0K
Principal Financial Group Inc	10,400	$20.0K
Insight Wealth Strategies, LLC	10,000	$19.0K
The PNC Financial Services Group, Inc.	5,000	$10.0K